These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35867969)

  • 1. Genomic landscapes of canine splenic angiosarcoma (hemangiosarcoma) contain extensive heterogeneity within and between patients.
    Wong S; Ehrhart EJ; Stewart S; Zismann V; Cawley J; Halperin R; Briones N; Richter K; Sivaprakasam K; Perdigones N; Contente-Cuomo T; Facista S; Trent JM; Murtaza M; Khanna C; Hendricks WPD
    PLoS One; 2022; 17(7):e0264986. PubMed ID: 35867969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of genomic alterations with clinical impact in canine splenic hemangiosarcoma.
    Estabrooks T; Gurinovich A; Pietruska J; Lewis B; Harvey G; Post G; Lambert L; Miller A; Rodrigues L; White ME; Lopes C; London CA; Megquier K
    Vet Comp Oncol; 2023 Dec; 21(4):623-633. PubMed ID: 37734854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the oncogenomic landscape of canine and feline hemangiosarcoma shows novel parallels with human angiosarcoma.
    Wong K; Ludwig L; Krijgsman O; Adams DJ; Wood GA; van der Weyden L
    Dis Model Mech; 2021 Jul; 14(7):. PubMed ID: 34296746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular subtypes in canine hemangiosarcoma reveal similarities with human angiosarcoma.
    Wang G; Wu M; Durham AC; Radaelli E; Mason NJ; Xu X; Roth DB
    PLoS One; 2020; 15(3):e0229728. PubMed ID: 32210430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Actionable mutations in canine hemangiosarcoma.
    Wang G; Wu M; Maloneyhuss MA; Wojcik J; Durham AC; Mason NJ; Roth DB
    PLoS One; 2017; 12(11):e0188667. PubMed ID: 29190660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromatin run-on sequencing analysis finds that ECM remodeling plays an important role in canine hemangiosarcoma pathogenesis.
    Mukai C; Choi E; Sams KL; Klampen EZ; Anguish L; Marks BA; Rice EJ; Wang Z; Choate LA; Chou SP; Kato Y; Miller AD; Danko CG; Coonrod SA
    BMC Vet Res; 2020 Jun; 16(1):206. PubMed ID: 32571313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Genomics Reveals Shared Mutational Landscape in Canine Hemangiosarcoma and Human Angiosarcoma.
    Megquier K; Turner-Maier J; Swofford R; Kim JH; Sarver AL; Wang C; Sakthikumar S; Johnson J; Koltookian M; Lewellen M; Scott MC; Schulte AJ; Borst L; Tonomura N; Alfoldi J; Painter C; Thomas R; Karlsson EK; Breen M; Modiano JF; Elvers I; Lindblad-Toh K
    Mol Cancer Res; 2019 Dec; 17(12):2410-2421. PubMed ID: 31570656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of microRNA expression profiles from splenic hemangiosarcoma, splenic nodular hyperplasia, and normal spleens of dogs.
    Grimes JA; Prasad N; Levy S; Cattley R; Lindley S; Boothe HW; Henderson RA; Smith BF
    BMC Vet Res; 2016 Dec; 12(1):272. PubMed ID: 27912752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of circulating tumor DNA analysis in dogs with naturally occurring malignant and benign splenic lesions.
    Favaro PF; Stewart SD; McDonald BR; Cawley J; Contente-Cuomo T; Wong S; Hendricks WPD; Trent JM; Khanna C; Murtaza M
    Sci Rep; 2022 Apr; 12(1):6337. PubMed ID: 35428782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum thymidine kinase activity in canine splenic hemangiosarcoma*.
    Thamm DH; Kamstock DA; Sharp CR; Johnson SI; Mazzaferro E; Herold LV; Barnes SM; Winkler K; Selting KA
    Vet Comp Oncol; 2012 Dec; 10(4):292-302. PubMed ID: 22236280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refining the "double two-thirds" rule: Genotype-based breed grouping and clinical presentation help predict the diagnosis of canine splenic mass lesions in 288 dogs.
    Davies O; Taylor AJ
    Vet Comp Oncol; 2020 Dec; 18(4):548-558. PubMed ID: 32043696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of serum microRNAs with differential expression between dogs with splenic masses and healthy dogs with histologically normal spleens.
    Grimes JA; Robinson KR; Bullington AM; Schmiedt JM
    Am J Vet Res; 2021 Aug; 82(8):659-666. PubMed ID: 34296940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective observational study of dogs with splenic mass rupture suggests potentially lower risk of malignancy and more favourable perioperative outcomes.
    Stewart SD; Ehrhart EJ; Davies R; Khanna C
    Vet Comp Oncol; 2020 Dec; 18(4):811-817. PubMed ID: 32458544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can CT texture analysis parameters be used as imaging biomarkers for prediction of malignancy in canine splenic tumors?
    Choi BK; Park S; Lee G; Chang D; Jeon S; Choi J
    Vet Radiol Ultrasound; 2023 Mar; 64(2):224-232. PubMed ID: 36285434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical detection of a potential molecular therapeutic target for canine hemangiosarcoma.
    Adachi M; Hoshino Y; Izumi Y; Takagi S
    J Vet Med Sci; 2016 May; 78(4):649-56. PubMed ID: 26685984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot safety evaluation of doxorubicin chemotherapy combined with non-specific immunotherapy (Immunocidin®) for canine splenic hemangiosarcoma.
    Musser ML; Coto GM; Lingnan Y; Mochel JP; Johannes CM
    PLoS One; 2022; 17(12):e0279594. PubMed ID: 36548371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of hemangiosarcoma in anemic dogs with a splenic mass and hemoperitoneum requiring a transfusion: 71 cases (2003-2005).
    Hammond TN; Pesillo-Crosby SA
    J Am Vet Med Assoc; 2008 Feb; 232(4):553-8. PubMed ID: 18279091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic profiling reveals extensive heterogeneity in somatic DNA copy number aberrations of canine hemangiosarcoma.
    Thomas R; Borst L; Rotroff D; Motsinger-Reif A; Lindblad-Toh K; Modiano JF; Breen M
    Chromosome Res; 2014 Sep; 22(3):305-19. PubMed ID: 24599718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperferritinemia in dogs with splenic hemangiosarcoma.
    Chikazawa S; Hori Y; Hoshi F; Kanai K; Ito N; Higuchi S
    J Vet Med Sci; 2013 Nov; 75(11):1515-8. PubMed ID: 23803459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splenic masses in dogs. Part 1: Epidemiologic, clinical characteristics as well as histopathologic diagnosis in 249 cases (2000-2011).
    Eberle N; von Babo V; Nolte I; Baumgärtner W; Betz D
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012; 40(4):250-60. PubMed ID: 22911256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.